Source link : https://www.newshealth.biz/health-news/no-apparent-harm-from-omitting-lymph-node-dissection-in-selected-breast-cancers/
SAN ANTONIO — Patients with early breast cancer who skipped axillary lymph node dissection (ALND) lived just as long as those who underwent sentinel lymph node biopsy (SLNB), the randomized INSEMA trial showed. The estimated 5-year invasive disease-free survival (IDFS) rate was 91.9% in patients who omitted ALND and 91.7% for those who had SLNB. […]
Author : News Health
Publish date : 2024-12-13 15:40:15
Copyright for syndicated content belongs to the linked Source.